Matthew Scalo

Matthew Scalo

Investor Relations Contact presso MYRIAD GENETICS, INC.

Finance
Health Technology
Consumer Services

Profilo

Matthew Scalo is currently a Senior Vice President & Investor Relations at Myriad Genetics, Inc. He previously worked as a Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc., VP, Investor Relations & Corporate Development at Cutera, Inc., and Associate at Broadpoint.
Gleacher Securities.
He also worked as a Research Analyst at Canaccord Genuity, Inc. Mr. Scalo holds an MBA degree from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Posizioni attive di Matthew Scalo

SocietàPosizioneInizio
MYRIAD GENETICS, INC. Investor Relations Contact 01/08/2022
Tutte le posizioni attive di Matthew Scalo

Precedenti posizioni note di Matthew Scalo

SocietàPosizioneFine
Analyst-Equity 31/12/2010
Analyst-Equity 22/04/2010
Analyst-Equity 31/12/2003
Analyst-Equity 31/12/2002
NEXTGEN HEALTHCARE, INC. Investor Relations Contact -
Vedi nel dettaglio l'esperienza di Matthew Scalo

Formazione di Matthew Scalo

University of Notre Dame Masters Business Admin
University of California, Davis Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Matthew Scalo

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
MYRIAD GENETICS, INC.

Health Technology

CUTERA, INC.

Health Technology

Aziende private6

Technology Services

Finance

Health Technology

Finance

Finance

Finance

Vedi le connessioni aziendali